Product Code: ETC7664669 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Viral Inactivation Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Viral Inactivation Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Viral Inactivation Market - Industry Life Cycle |
3.4 Israel Viral Inactivation Market - Porter's Five Forces |
3.5 Israel Viral Inactivation Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Viral Inactivation Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Israel Viral Inactivation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for biological products and vaccines in Israel |
4.2.2 Stringent regulations and guidelines for viral safety in pharmaceutical and biotechnology industries |
4.2.3 Growing investments in research and development activities related to viral inactivation technologies |
4.3 Market Restraints |
4.3.1 High costs associated with viral inactivation processes |
4.3.2 Limited awareness and adoption of advanced viral inactivation technologies in Israel |
5 Israel Viral Inactivation Market Trends |
6 Israel Viral Inactivation Market, By Types |
6.1 Israel Viral Inactivation Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Viral Inactivation Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Viral Inactivation Market Revenues & Volume, By Kits and Reagents, 2021- 2031F |
6.1.4 Israel Viral Inactivation Market Revenues & Volume, By Services, 2021- 2031F |
6.1.5 Israel Viral Inactivation Market Revenues & Volume, By Viral Inactivation Systems and Accessories, 2021- 2031F |
6.2 Israel Viral Inactivation Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Viral Inactivation Market Revenues & Volume, By Blood and Blood Products, 2021- 2031F |
6.2.3 Israel Viral Inactivation Market Revenues & Volume, By Cellular and Gene Therapy Products, 2021- 2031F |
6.2.4 Israel Viral Inactivation Market Revenues & Volume, By Stem Cell Products, 2021- 2031F |
6.2.5 Israel Viral Inactivation Market Revenues & Volume, By Tissue and Tissue Products, 2021- 2031F |
6.2.6 Israel Viral Inactivation Market Revenues & Volume, By Vaccines and Therapeutics, 2021- 2031F |
7 Israel Viral Inactivation Market Import-Export Trade Statistics |
7.1 Israel Viral Inactivation Market Export to Major Countries |
7.2 Israel Viral Inactivation Market Imports from Major Countries |
8 Israel Viral Inactivation Market Key Performance Indicators |
8.1 Percentage of pharmaceutical companies adopting viral inactivation technologies in Israel |
8.2 Research and development expenditure on viral inactivation technologies in Israel |
8.3 Number of patents filed for new viral inactivation technologies in Israel. |
9 Israel Viral Inactivation Market - Opportunity Assessment |
9.1 Israel Viral Inactivation Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Viral Inactivation Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Israel Viral Inactivation Market - Competitive Landscape |
10.1 Israel Viral Inactivation Market Revenue Share, By Companies, 2024 |
10.2 Israel Viral Inactivation Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |